CannaPharmaRx Inc
OTC:CPMD

Watchlist Manager
CannaPharmaRx Inc Logo
CannaPharmaRx Inc
OTC:CPMD
Watchlist
Price: 0.0045 USD 12.5% Market Closed
Market Cap: 3m USD

Net Margin
CannaPharmaRx Inc

-415.6%
Current
-1 871%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-415.6%
=
Net Income
-5.7m
/
Revenue
1.4m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
CA
CannaPharmaRx Inc
OTC:CPMD
3m USD
-416%
US
Eli Lilly and Co
NYSE:LLY
993.4B USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
508.5B USD
27%
CH
Roche Holding AG
SIX:ROG
256.1B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
209.1B GBP
16%
CH
Novartis AG
SIX:NOVN
206.4B CHF
26%
US
Merck & Co Inc
NYSE:MRK
243.7B USD
30%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
33%
IE
Endo International PLC
LSE:0Y5F
209B USD
-126%
US
Pfizer Inc
NYSE:PFE
142.5B USD
16%
No Stocks Found

CannaPharmaRx Inc
Glance View

Market Cap
3m USD
Industry
Pharmaceuticals

CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. The company is headquartered in Calgary, Alberta and currently employs 4 full-time employees. The principal activity of the Company is to negotiate, acquire and develop various cannabis cultivation projects throughout Canada. The firm's activities is centered around projects, such as the Great Northern Project, and the acquisition of Ramon Road Production Campus LLC. The firm is focused on producing wholesale cannabis and hemp for the medical market.

CPMD Intrinsic Value
0.0042 USD
Overvaluation 6%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-415.6%
=
Net Income
-5.7m
/
Revenue
1.4m
What is the Net Margin of CannaPharmaRx Inc?

Based on CannaPharmaRx Inc's most recent financial statements, the company has Net Margin of -415.6%.

Back to Top